Watch a Tree Release a Massive "Pollen Bomb" Into the Air

iStock
iStock

In case your itchy, watery eyes hadn't already tipped you off, spring is in the air. Some trees release up to a billion pollen grains apiece each year, and instead of turning into baby trees, many of those spores end up in the noses of allergy sufferers. For a visual of just how much pollen is being released into our backyards, check out the video below spotted by Gothamist.

This footage was captured by Millville, New Jersey resident Jennifer Henderson while her husband was clearing away brush with a backhoe. He noticed one tree was blanketed in pollen, and decided to bump into it to see what would happen. The result was an explosion of plant matter dramatic enough to make you sniffle just by looking at it.

"Pollen bombs" occur when the weather starts to warm up after a prolonged winter, prompting trees and grasses to suddenly release a high concentration of pollen in a short time span. Wind, temperature, and humidity levels all determine the air's pollen count for any given day, but allergy season settles down around May.

After determining that your congestion is the result of allergies and not a head cold, there are a few steps you can take to stave off symptoms before they appear. Keep track of your area's pollen report throughout the week, and treat yourself with antihistamines or nasal spray on days when you know it will be particularly bad outside. You can also keep your home a pollen-free zone by closing all the windows and investing in an air purifier. Check out our full list of seasonal allergy-fighting tips here.

[h/t Gothamist]

FDA Recalls Thyroid Medications Due to Contamination Risk

iStock
iStock

Hypothyroid medications manufactured by Westminster Pharmaceuticals have been recalled after it was discovered that one of the company’s Chinese suppliers failed to meet U.S. Food and Drug Administration (FDA) standards, CNN reports.

The oral tablets contain levothyroxine (LT4) and liothyronine (LT3), which are both synthetic hormones used to treat thyroid conditions.

The medicine was recalled as a precaution after it was discovered during a 2017 FDA inspection that the Chinese supplier in question, Sichuan Friendly Pharmaceutical Co., was not practicing good manufacturing practices.

However, patients with serious thyroid conditions shouldn’t throw out their pills just yet. No adverse effects from the medication have been reported, and the risk of not taking the medication outweighs the risk of taking a recalled pill.

According to the FDA, “Because these products may be used in the treatment of serious medical conditions, patients taking the recalled medicines should continue taking their medicine until they have a replacement product.”

For more information on the specific lots and products in question, visit the FDA’s website.

[h/t CNN]

A 'Zombie Gene' Might Be the Reason Elephants Rarely Get Cancer

iStock
iStock

When it comes to cancer rates in the animal kingdom, elephants are an anomaly. As Popular Science notes, cancer should be more common among larger species, but with elephants, that simply isn’t the case. Only about 5 percent of elephants die from cancer, compared to 11 to 25 percent of humans.

In a new study, published in Cell Reports, University of Chicago researchers found what’s believed to be the genetic source of elephants’ cancer immunity. Elephants, like all mammals, have a gene called LIF that is known to suppress tumors. Humans have one copy of this gene, but elephants have 10 copies, which have developed over 80 million years of evolution. However, only one of those copies, called LIF6, is functional in elephants.

The other LIF copies are essentially dead because they lack a specific piece of DNA to make them function. At some point during the evolutionary process, the LIF6 gene copy turned back on, but scientists don’t know why or when this occurred. This “zombie gene” helps kill mutated cells, in true Night of the Living Dead fashion.

“This reanimation of LIF6 occurred perhaps over 59 million years,” Joshua Schiffman, who studies cancer in elephants but was not involved in the study, told Popular Science. “That’s an amazingly long period of time for nature to modify and perfect an anticancer mechanism.”

Scientists aren’t yet sure how this could be applied to cancer research in humans, but they say it’s a promising start and a creative approach to the problem. While these findings are still fresh and need to be duplicated, it raises the possibility of creating a drug that mimics the function of LIF6.

[h/t Popular Science]

SECTIONS

arrow
LIVE SMARTER
More from mental floss studios